SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-23-000071
Filing Date
2023-11-09
Accepted
2023-11-09 17:04:46
Documents
43
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks-20230930.htm   iXBRL 10-Q 588719
2 EX-31.1 slrx20230930ex-311.htm EX-31.1 8862
3 EX-31.2 slrx20230930ex-312.htm EX-31.2 8652
4 EX-32.1 slrx20230930ex-321.htm EX-32.1 6181
  Complete submission text file 0001615219-23-000071.txt   3161085

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20230930.xsd EX-101.SCH 21494
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20230930_cal.xml EX-101.CAL 27898
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20230930_def.xml EX-101.DEF 97907
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20230930_lab.xml EX-101.LAB 342729
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20230930_pre.xml EX-101.PRE 210675
37 EXTRACTED XBRL INSTANCE DOCUMENT flks-20230930_htm.xml XML 266635
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 231393625
SIC: 2834 Pharmaceutical Preparations